| 01st week of 2017 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20170000703 | COMPOSITIONS AND METHODS COMPRISING SIRTUINS | 2017-01-05 |
| 20170000704 | PERSONAL CARE COMPOSITIONS COMPRISING A SENSATE | 2017-01-05 |
| 20170000705 | COMPOSITION BASED ON A POLYUNSATURATED FATTY ACID AND ON A CAROTENOID, FOR ORAL ADMINISTRATION, FOR IMPROVING HAIR QUALITY | 2017-01-05 |
| 20170000706 | ANTIMICROBIAL COMPOSITIONS CONTAINING LOW CONCENTRATIONS OF FOOD ALLOWED ORGANIC ACIDS AND AMINE OXIDE AMPHOTERIC SURFACTANTS | 2017-01-05 |
| 20170000707 | Method for Dyeing Keratin Fibres | 2017-01-05 |
| 20170000708 | GRADUAL HAIRCOLOR COMPOSITIONS AND METHODS OF USING THE SAME | 2017-01-05 |
| 20170000709 | EMULSIONS COMPRISING CATIONIC EMULSIFIERS BASED ON MDIPA ESTER QUATS | 2017-01-05 |
| 20170000710 | Conditioning Shampoos Containing Anionic Surfactants, Glucamides, And Fatty Alcohols | 2017-01-05 |
| 20170000711 | FOAM COMPOSITIONS, AEROSOL PRODUCTS, AND METHODS OF USING THE SAME TO IMPROVE SENSORY BENEFITS TO THE SKIN | 2017-01-05 |
| 20170000712 | SUNLESS TANNING COMPOUNDS AND COMPOSITIONS | 2017-01-05 |
| 20170000713 | PERSONAL CARE COMPOSITIONS COMPRISING A SENSATE | 2017-01-05 |
| 20170000714 | COMPOSITION CONTAINING FUCOSTEROL FOR SKIN WHITENING OR MOISTURIZING | 2017-01-05 |
| 20170000715 | PEGYLATED 7-DEHYDROCHOLESTEROL DERIVATIVES | 2017-01-05 |
| 20170000716 | LUMINATE EYE GEL | 2017-01-05 |
| 20170000717 | A COMPOSITION OF MATTER AND METHOD OF USE FOR A NUTRITIONAL SUPPLEMENT | 2017-01-05 |
| 20170000718 | AEROSOL COMPOSITION COMPRISING A PARTICULATE TAPIOCA STARCH | 2017-01-05 |
| 20170000719 | AEROSOL COMPOSITION COMPRISING A PARTICULATE TAPIOCA STARCH | 2017-01-05 |
| 20170000720 | COMPOSITION FOR EXTERNAL APPLICATION TO SKIN | 2017-01-05 |
| 20170000721 | LIQUID COMPOSITIONS FOR HAIR REMOVAL DEVICES | 2017-01-05 |
| 20170000722 | Emulsion Of Cross-linked Aminosiloxane Polymer | 2017-01-05 |
| 20170000723 | ORGANOPOLYSILOXANE AND HAIR COSMETIC AND METHOD FOR PRODUCING THEREOF | 2017-01-05 |
| 20170000724 | COMPOSITION DERIVED FROM STEM CELL RELEASED MOLECULES & METHODS FOR FORMULATION THEREOF | 2017-01-05 |
| 20170000725 | COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2017-01-05 |
| 20170000726 | Compositions and Methods for the Delivery of Agents | 2017-01-05 |
| 20170000727 | DRY ENEMA PRODUCT | 2017-01-05 |
| 20170000728 | Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders | 2017-01-05 |
| 20170000729 | METHODS AND COMPOSITIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2017-01-05 |
| 20170000730 | OPHTHALMIC DRUG DELIVERY METHOD | 2017-01-05 |
| 20170000731 | IMPLANT DEVICE FOR DRUG DELIVERY | 2017-01-05 |
| 20170000732 | DIACEREIN OR RHEIN TOPICAL FORMULATIONS AND USES THEREOF | 2017-01-05 |
| 20170000733 | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF DRUGS AND LIPOPHILIC MICROPHASE-FORMING MATERIALS | 2017-01-05 |
| 20170000734 | Compositions and Methods for Improved Encapsulation of Functional Proteins in Polymeric Vesicles | 2017-01-05 |
| 20170000735 | EPINEPHRINE NANOPARTICLES, METHODS OF FABRICATION THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE | 2017-01-05 |
| 20170000736 | ENCAPSULATED ACTIVE INGREDIENTS FOR CONTROLLED ENTERIC RELEASE | 2017-01-05 |
| 20170000737 | HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF | 2017-01-05 |
| 20170000738 | LYOPHILIZED PHARMACEUTICAL COMPOSITIONS | 2017-01-05 |
| 20170000739 | ABUSE-PROOFED DOSAGE FORM | 2017-01-05 |
| 20170000740 | COMBINATION THERAPEUTIC NANOPARTICLES | 2017-01-05 |
| 20170000741 | MICROCAPSULES WITH POLYMERIC COATING COMPRISING A LIPID AND AN ACTIVE AGENT | 2017-01-05 |
| 20170000742 | SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS FOR USING THE SAME | 2017-01-05 |
| 20170000743 | Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles | 2017-01-05 |
| 20170000744 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF CANNABINOIDS IN STANDARDIZED PRECISION-METERED DOSAGE FORMS | 2017-01-05 |
| 20170000745 | TRANSDERMAL DRUG DELIVERY SYSTEMS FOR LEVONORGESTREL AND ETHINYL ESTRADIOL | 2017-01-05 |
| 20170000746 | METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONS | 2017-01-05 |
| 20170000747 | USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF ACETAMINOPHEN OVERDOSE | 2017-01-05 |
| 20170000748 | METHOD FOR ENHANCING AMIDOHYDROLASE ACTIVITY OF FATTY ACID AMIDE HYDROLASE | 2017-01-05 |
| 20170000749 | Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase | 2017-01-05 |
| 20170000750 | [2.2.2] BICYCLIC DERIVATIVES AND METHODS OF USE | 2017-01-05 |
| 20170000751 | COMPOSITION FOR ACCELERATING PENETRATION THROUGH SKIN, PREPARATION FOR TRANSDERMAL ADMINISTRATION, AND SKIN PATCH PREPARATION | 2017-01-05 |
| 20170000752 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | 2017-01-05 |
| 20170000753 | KALLIKREIN 7 INHIBITORS | 2017-01-05 |
| 20170000754 | KETONE SUPPLEMENTS FOR TREATMENT OF ANGELMAN SYNDROME | 2017-01-05 |
| 20170000755 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | 2017-01-05 |
| 20170000756 | METHODS FOR TREATING OR PREVENTING FATIGUE | 2017-01-05 |
| 20170000757 | THERAPEUTIC APPLICATION OF (BOC)2-CREATINE | 2017-01-05 |
| 20170000758 | GEL COMPOSITION FOR TREATMENT OF COMMON ACNE COMPRISING A COMBINATION OF BENZOYL PEROXIDE AND ADAPALENE AND/OR ADAPALENE SALT | 2017-01-05 |
| 20170000759 | Pharmaceutical Composition Including 5--2,2-Dimethyl-4-(3-Fluorophenyl)-3(2H)-Furanone And Capsule Formulation Including The Pharmaceutical Composition | 2017-01-05 |
| 20170000760 | METHODS FOR INHIBITING CANCER CELLS | 2017-01-05 |
| 20170000761 | PROTECTING TISSUE AND MITIGATING INJURY FROM CHEMICAL EXPOSURE | 2017-01-05 |
| 20170000762 | ANTI-MICROBIAL COMPOSITION | 2017-01-05 |
| 20170000763 | ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION | 2017-01-05 |
| 20170000764 | PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY | 2017-01-05 |
| 20170000765 | TRIPTAN POWDERS FOR PULMONARY DELIVERY | 2017-01-05 |
| 20170000766 | Methods and Compositions Involving (S)-Bucindolol | 2017-01-05 |
| 20170000767 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR MULTIPLE SCLEROSIS | 2017-01-05 |
| 20170000768 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | 2017-01-05 |
| 20170000769 | NADPH Production by the 10-Formyl-THF Pathway, and Its Use in the Diagnosis and Treatment of Disease | 2017-01-05 |
| 20170000770 | CARBOXAMIDE DERIVATIVES | 2017-01-05 |
| 20170000771 | Thromboxane Receptor Antagonists in AERD/Asthma | 2017-01-05 |
| 20170000772 | SMALL MOLECULE MODULATORS OF PRB INACTIVATION | 2017-01-05 |
| 20170000773 | SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLES, METHODS FOR USE THEREOF | 2017-01-05 |
| 20170000774 | MYELOID DIFFERENTIATION INDUCING AGENTS | 2017-01-05 |
| 20170000775 | PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENTS | 2017-01-05 |
| 20170000776 | Method for Treatment of Radiologically-Dense Breasts | 2017-01-05 |
| 20170000777 | COMPOSITIONS, METHODS, AND KITS FOR REGULATING ENERGY METABOLISM | 2017-01-05 |
| 20170000778 | DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR | 2017-01-05 |
| 20170000779 | Modulation of Stem Cell and Progenitor Cell Differentiation, Assays, And Uses Thereof | 2017-01-05 |
| 20170000780 | COMPOSITIONS, METHODS AND KITS FOR REDUCING LIPID LEVELS | 2017-01-05 |
| 20170000781 | QUINOLINES AS FGFR KINASE MODULATORS | 2017-01-05 |
| 20170000782 | METHODS FOR TREATING PRURITUS | 2017-01-05 |
| 20170000783 | Multiparticulate Modified Release Composition | 2017-01-05 |
| 20170000784 | Autophagy Inhibitors | 2017-01-05 |
| 20170000785 | INHIBITORS OF THE FKBP51 PROTEIN FROM A HIGH-THROUGHPUT DRUG SCREEN AND METHODS OF USE | 2017-01-05 |
| 20170000786 | Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders | 2017-01-05 |
| 20170000787 | AURORA KINASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF | 2017-01-05 |
| 20170000788 | Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease | 2017-01-05 |
| 20170000789 | Methods of Treating Tumoral Diseases, or Bacterial or Viral Infections | 2017-01-05 |
| 20170000790 | SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY | 2017-01-05 |
| 20170000791 | MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT | 2017-01-05 |
| 20170000792 | HYDROCHLORIDE SALT OF((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL) METHYL SULFAMATE | 2017-01-05 |
| 20170000793 | METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING | 2017-01-05 |
| 20170000794 | METHODS FOR MODULATING THE AMOUNT OF RNA TRANSCRIPTS | 2017-01-05 |
| 20170000795 | Treatment of Neoplasia | 2017-01-05 |
| 20170000796 | PTERIDINES AS FGFR INHIBITORS | 2017-01-05 |
| 20170000797 | USE OF SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY | 2017-01-05 |
| 20170000798 | TREATMENT OF DEGENERATIONS AND LIGHT-INDUCED DAMAGE TO THE RETINA | 2017-01-05 |
| 20170000799 | ORAL PHARMACEUTICAL COMPOSITION | 2017-01-05 |
| 20170000800 | PYRROLO[2,1-F[1,2,4]TRIAZINE COMPOUNDS, PREPARATION METHODS AND APPLICATIONS THEREOF | 2017-01-05 |
| 20170000801 | TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS | 2017-01-05 |
| 20170000802 | Methods and Compositions for Treating Viral Diseases | 2017-01-05 |
